Fabian Coscia and his team have published in “Nature Methods” an open-source workflow that makes Deep Visual Proteomics easier to use, adapt and scale. OpenDVP enables scientists to spatially map thousands of proteins inside cells and their cellular…
Berlin Entrepreneur Receives Cross of Merit for Outstanding Service
3D bioprinting opens up new possibilities for producing organs and tissues needed for applications such as organ transplants and drug development. However, while existing bioinks are cell-compatible and printable, they do not adequately replicate the…
Deadline for application: 29 January 2027
GeneNovate® is a nationwide, free-of-charge entrepreneurship program for students, PhD candidates, postdocs, researchers, and physicians interested in developing innovative ideas in gene and cell therapies, biotechnology, and life sciences into…
Artificial intelligence (AI) is transforming healthcare at a rapid pace. It is changing how health data are collected, interpreted and applied across areas ranging from basic research and drug development to diagnostics, clinical decision support,…
Neurotech is reshaping the diagnosis and treatment of neurological and psychiatric disorders. In Berlin Brandenburg, the field is moving from research into practical application through brain-computer interfaces, digital therapies and non-invasive…
Eckert & Ziegler Brazil, a regional subsidiary of the global nuclear medicine group Eckert & Ziegler SE (ISIN DE0005659700, TecDAX), and TerThera announced today the signing of a strategic supply agreement for the precursor Terbium-161.
The Berlin Center for HIV Cure bundles interdisciplinary expertise on HIV and provides access to the latest, leading-edge clinical trials
B# Plus stärkt Berliner Biotech-Gründerinnen bei der Entwicklung einer wegweisenden Gen-Reparaturtherapie gegen genetisch bedingten Muskelschwund.
